BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yagi K, Asakura T, Namkoong H, Suzuki S, Asami T, Okamori S, Kusumoto T, Funatsu Y, Kamata H, Nishimura T, Ishii M, Betsuyaku T, Hasegawa N. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease. BMC Pulm Med 2018;18:114. [PMID: 30005658 DOI: 10.1186/s12890-018-0686-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lan CC, Lai SR, Chien JY. Nonpharmacological treatment for patients with nontuberculous mycobacterial lung disease. J Formos Med Assoc 2020;119 Suppl 1:S42-50. [PMID: 32499207 DOI: 10.1016/j.jfma.2020.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ono K, Tabusadani M, Yamane K, Takao S, Mori K, Matsumura Y, Kuroyama Y, Kawahara K, Omatsu S, Furuuchi K, Fujiwara K, Morimoto K, Kimura H, Senjyu H. Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary disease. Expert Rev Respir Med 2022. [PMID: 35245168 DOI: 10.1080/17476348.2022.2049762] [Reference Citation Analysis]
3 Tanaka H, Asakura T, Suzuki S, Okamori S, Kusumoto T, Ogawa T, Uno S, Morita A, Lee H, Namkoong H, Kamata H, Sato Y, Uwamino Y, Nishimura T, Ishii M, Fukunaga K, Hasegawa N. Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study. BMC Pulm Med 2022;22:202. [PMID: 35596169 DOI: 10.1186/s12890-022-01991-3] [Reference Citation Analysis]
4 Hemnes AR, Silverman-Loyd L, Huang S, MacKinnon G, Annis J, Whitmore CS, Mallugari R, Oggs RN, Hekmat R, Shan R, Huynh PP, Yu C, Martin SS, Blaha MJ, Brittain EL. A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension. Chest 2021:S0012-3692(21)00699-1. [PMID: 33878341 DOI: 10.1016/j.chest.2021.04.012] [Reference Citation Analysis]
5 Takao S, Tabusadani M, Yamane K, Kakuta T, Kuroyama Y, Mori K, Ono K, Omatsu S, Kawahara K, Toyoda Y, Senjyu H. Is the Leicester Cough Questionnaire useful for nontuberculous mycobacterial lung disease? Respir Investig 2021;59:120-5. [PMID: 32800755 DOI: 10.1016/j.resinv.2020.06.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Blakney RA, Ricotta EE, Follmann D, Drew J, Carey KA, Glass LN, Robinson C, Macdonald S, Mcshane PJ, Olivier KN, Fennelly K, Prevots DR. The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07054-6] [Reference Citation Analysis]
7 Yamane K, Furuuchi K, Tabusadani M, Takao S, Kuroyama Y, Matsumura Y, Mori K, Ono K, Kawahara K, Omatsu S, Toyoda Y, Fujiwara K, Morimoto K, Senjyu H. Influence of chronic sputum symptoms on quality of life in patients with nontuberculous mycobacterial pulmonary disease: A cross-sectional study. Respir Investig 2021:S2212-5345(21)00179-9. [PMID: 34764045 DOI: 10.1016/j.resinv.2021.09.011] [Reference Citation Analysis]
8 Yagi K, Ito A, Fujiwara K, Morino E, Hase I, Nakano Y, Asakura T, Furuuchi K, Morita A, Asami T, Namkoong H, Saito F, Morimoto K, Ishii M, Sato Y, Tateno H, Nishio K, Oyamada Y, Fukunaga K, Sugiyama H, Ishida T, Kurashima A, Hasegawa N. Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis: A Multicenter Retrospective Study. Ann Am Thorac Soc 2021;18:1490-7. [PMID: 33832404 DOI: 10.1513/AnnalsATS.202008-938OC] [Reference Citation Analysis]